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Introduction: SALL4 and BMI-1 are important factors in hematopoiesis. Placental tissue (PT) and umbilical cord
blood (CB) are rich in hematopoietic stem/progenitor cells (HSCs/HPCs), but their SALL4 and BMI-1 expression levels
remain unknown.
Methods: Real-time PCR was used to determine the expression level of these genes in PT and CB from ten cases,
and ten healthy donors were used as controls.
Results: A significantly higher BMI-1 and SALL4 gene expression level was found in PT (median: 17.548 and 34.362,
respectively) than in cord blood mononuclear cells (CBMCs) (median: 2.071 and 11.300, respectively) (P = 0.0001 and
P = 0.007) and healthy peripheral blood mononuclear cells (PBMCs) (median: 0.259 and 0.384, respectively) (P = 0.001
and P <0.0001), and their expression level was lower in PBMCs than in CBMCs (P = 0.029 and P = 0.002). A positive
correlation between the BMI-1 and SALL4 genes was found in the PT and CB groups, while there was no significant
correlation between these genes in the healthy group. There was also no significant correlation between the
expression level of each gene in PT and CB.
Conclusions: These results describe the characteristic features of the BMI-1 and SALL4 gene expression pattern in
placental tissue and cord blood. Placental tissue with higher expression level of both genes may be considered as a
potential resource for SALL4-related HPC expansion.
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Umbilical cord blood (CB) is a valuable alternative he-
matopoietic stem cells (HSC) source for transplantations
for patients who lack a suitable sibling donor [1-3]. It
has been demonstrated previously that CB-derived pro-
genitors can express Oct3/4, SRY-related HMG-box 2
(Sox2), Nanog and reduced expression-1 (Rex1), which
are pluripotent/multilineage markers and could poten-
tially differentiate into multiple lineages [4,5]. However,
different gene expression pattern may determine the use
of human CB-derived HSCs/hematopoietic progenitor
cells (HPCs) as functional tissues or cells [6].* Correspondence: yangqiuli@hotmail.com
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reproduction in any medium, provided the orSal-like protein 4 (SALL4) and B cell-specific MLV
integration site 1 (BMI-1) are important factors in he-
matopoiesis and are expressed in hematopoietic stem/
progenitor cells (HSCs/HPCs) and myeloid leukemia
cells [7]. Placental tissue (PT) and CB comprise rich
HSCs/HPCs; however, little is known about the diffe-
rence in the expression level of SALL4 and BMI-1 in PT
and CB.
SALL4, a newly identified zinc-finger transcription
factor that is a member of the SALL gene family, was
originally cloned based on its sequence homology to
Drosophila spalt (sal) [7,8]. This protein plays important
roles in maintaining embryonic stem cells (ESC) plu-
ripotency and HSC/HPC self-renewal properties, and it
has been recently proposed for use in CB expansion
[9]. Recently, it was demonstrated that BMI-1 is a
direct SALL4 target gene. BMI-1 is a member of the po-
lycomb group of proteins, and it was initially identified intd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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protein is highly expressed in purified HSCs, its expres-
sion declines with differentiation [7,11], and it plays an es-
sential role in regulating adult, self-renewing HSCs/HPCs
[7,11-13]. The induction of SALL4 expression is associated
with increased levels of histone H3-K4 and H3-K79 me-
thylation in the BMI-1 promoter, indicating a novel
connection between SALL4 and the polycomb group
proteins [7].
In this study, we sought to characterize the expression
pattern of the BMI-1 and SALL4 genes in PT and CB.Materials and methods
Samples
Ten placental tissue samples were obtained from full-
term deliveries, and umbilical cord blood was obtained
at the same time from full-term healthy babies with the
mothers’ consent. All human tissue and cell samples
were obtained with consent from the human subjects.
Peripheral blood samples from ten healthy donors with
informed consent were used as control. All of the proce-
dures were conducted according to the guidelines of the
Medical Ethics Committees of the Health Bureau of the
Guangdong Province of China, and ethical approval was
obtained from the Ethics Committee of Medical School
of Jinan University for this study.Quantitative real-time reverse transcription-polymerase
chain reaction (qRT-PCR)
Mononuclear cells were isolated from cord blood sam-
ples (CBMCs) and healthy peripheral blood (PBMCs) by
Ficoll-Hypaque gradient centrifugation. The placental
tissue (approximately 100 mg) was obtained by curettage
of the central portion of the placenta (decidua in majo-
rity). RNA isolation and cDNA synthesis were performed
according to the manufacturer’s protocol [14].Figure 1 Expression level of SALL4 and BMI-1. Expression level of the SA
peripheral blood mononuclear cells (CBMCs and PBMCs, respectively) from
three groups.The expression level of BMI-1, SALL4, and the β2
microglobulin (β2-MG) reference gene was determined
by SYBR Green I real-time PCR as previously des-
cribed [15].
Statistical analyses
Differences in mRNA expression between two groups
were analyzed using the Mann-Whitney test. Data are
presented as the median. Spearman’s rank correlation
analysis was used to analyze the SALL4 and BMI-1 mRNA
levels in different samples. Differences were considered
statistically significant with a P <0.05.
Results and Discussion
Due to its wide availability, low cost and lack of ethical
concerns, CB provides an attractive source of stem cells
for investigational and therapeutic uses [1-3]. Recently,
in the promising field of regenerative medicine, human
perinatal stem cells that could be isolated from normally
discarded human placentae are of great interest as po-
tential stem cells with clinical applications. Perinatal
stem cells are an ideal cell source in terms of availability,
the fewer number of ethical concerns, less DNA damage,
and so on [16,17]. The biological characteristics of CB-
derived HSCs/HPCs were characterized in numerous
studies [4,6]. SALL4 may act as a critical regulator of the
fate of hematopoietic cells. In normal bone marrow,
SALL4 is selectively expressed in primitive hematopoie-
tic precursors and is rapidly downregulated following
differentiation. Therefore, the SALL4 gene expression
level should be positively correlated with stem cells [7].
However, little is known about the difference in the ex-
pression level of SALL4 in CB; thus, it may be interest-
ing to determine the expression characteristics of this
gene in PT collected from the same case as the CB to
compare expression pattern differences. In this study, we
found that the SALL4 expression level was higher in PTLL4 (A) and BMI-1 (B) genes in placental tissue (PT), cord blood and
healthy individuals (HI). A significant difference was found among the
Figure 2 Correlation of expression level of SALL-4 and BMI-1 in different samples. Correlation analysis of the relative expression level of the
BMI-1 and SALL4 genes in placental tissue (PT) (A), cord blood mononuclear cells (CBMCs) (B) and peripheral blood mononuclear cells (PBMCs) (C).
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P = 0.007) and PBMCs (median: 0.384; P < 0.0001), and a
lower SALL4 expression level was found in PBMCs than
CBMCs (Figure 1A; P = 0.002). It has been reported that
SALL4-expanded HSCs/HPCs retain multilineage re-
population and long-term engraftment abilities, which
are clinically significant [18]. Thus, SALL4 could be used
to stimulate the large scale ex vivo expansion of HSCs/
HPCs, and it is particularly interesting whether SALL4-
rich placental tissue is able to be used as a resource for
HSC/HPC expansion.
Because BMI-1 is a direct SALL4 target gene [7],
BMI-1 expression may be correlated with that of SALL4.
Our results also demonstrated that the BMI-1 gene ex-
pression level was significantly higher in PT (median:
17.548) than that in CBMCs (median: 2.071; P = 0.0001)
and PBMCs (median: 0.259; P = 0.001), and its expres-
sion level was lower in PBMCs than that in CBMCs
(Figure 1B; P = 0.029). A positive correlation between
the BMI-1 and SALL4 genes was found in the PT
and CB groups (rs = 0.648, P = 0.043 and rs = 0.721,
P = 0.019, respectively), while there was no significant
correlation between these genes in the healthy group
(rs = -0.212, P = 0.556) (Figure 2). This result further
supports the finding of a relationship between the ex-
pression pattern of BMI-1 and SALL4 in HSC/HPC-richFigure 3 Correlation of expression level of BMI-1 and SALL4 between
BMI-1 (A) and SALL4 (B) genes in placental tissue (PT) and cord blood monCB and placental tissue, while PBMCs contain only lim-
ited BMI-1 and SALL4 expression, which may reflect their
expression in different levels of HPCs and myeloid cells
[7]. Moreover, this result may indicate that the PT niche
contains hematopoietic transcription factors that are able
to enhance HPC expansion. It is thought that the expres-
sion level of genes in PT and CB derived from the same
case may demonstrate a positive correlation; however,
interestingly, the expression levels of BMI-1 and SALL4
were not significantly correlated between the PT and CB
(Figure 3). This result may be related to a difference in the
HSC/HPC numbers in CB or may imply that placental
tissue-derived HSCs/HPCs have a different SALL4 and
BMI-1 expression pattern. Further analysis is needed to
compare the expression levels of these genes and the per-
centages of HSCs/HPCs in CB and PT.
Conclusions
We determined the expression characteristics of BMI-1
and SALL4 in placental tissue and cord blood. The
results of this study may contribute to a better under-
standing of the expression characteristics and correlation
of SALL4 and BMI-1 in placenta tissue. Placental tissue
with higher expression level of both genes may be con-
sidered as a potential resource for SALL4-related HPC
expansion.PT and CB. Correlation analysis of the relative expression level of the
onuclear cells (CBMCs).
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BMI-1: B cell-specific MLV integration site 1 gene; CB: umbilical cord blood;
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